Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP

Withdrawn

Conditions: Cholangiocarcinoma

First Posted Date: 2011-09-23

Last Posted Date: 2015-06-03

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT01439685

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry

Conditions: Bile Duct Obstruction
Bile Duct Cancer
Biliary Stricture
Cholangiocarcinoma
Pancreatic Cancer

Interventions: Device: Radio Frequency ablation Probe

First Posted Date: 2011-09-23

Last Posted Date: 2017-02-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT01439698

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Weill Cornell Medical College, New York, New York, United States

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Conditions: Pediatric Gastroenterology
Cholangiocarcinoma
Recurrent Pancreatitis
Cholangitis
Bile Leak
Biliary and Pancreatic Stones
Gallstones
Gastric Malignancies
Pancreatic Cancer
Pancreatic Divisum

Interventions: Procedure: Interventional Endoscopy

First Posted Date: 2011-09-22

Last Posted Date: 2017-02-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 12000

Registration Number: NCT01438385

Locations: 🇺🇸
Weill Cornell Medical College of Cornell University, New York, New York, United States

Sustaining Remission of Psychotic Depression

Phase 4

Completed

Conditions: Psychotic Depression

Interventions: Drug: Sertraline + Olanzapine
Drug: Sertraline + Placebo

First Posted Date: 2011-09-01

Last Posted Date: 2019-03-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 269

Registration Number: NCT01427608

Locations: 🇺🇸
Anthony Rothschild, MD, Worcester, Massachusetts, United States
🇺🇸
George Alexopoulos, MD, White Plains, New York, United States
🇺🇸
Ellen Whyte, MD, Pittsburgh, Pennsylvania, United States

and more 1 locations

AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis

Phase 1

Completed

Conditions: Batten Disease
Late Infantile Neuronal Ceroid Lipofuscinosis

Interventions: Biological: AAVrh.10CUCLN2

First Posted Date: 2011-08-11

Last Posted Date: 2020-08-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 8

Registration Number: NCT01414985

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy

Phase 1

Completed

Conditions: Idiopathic Intracranial Hypertension (IIH)

Interventions: Device: Venous Sinus Stenting

First Posted Date: 2011-08-02

Last Posted Date: 2020-08-03

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT01407809

Locations: 🇺🇸
New York Presbyterian/ Weill Cornell Medicine, New York, New York, United States

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Phase 2

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Fresolimumab
Radiation: Radiation Therapy

First Posted Date: 2011-07-25

Last Posted Date: 2019-03-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 23

Registration Number: NCT01401062

Locations: 🇺🇸
David Geffen School of Medicine at UCLA, Los Angeles, California, United States
🇺🇸
New York University Langone Medical Center Cancer Center, New York, New York, United States

Vitamin D and Glucose Metabolism in Pediatrics

Phase 4

Conditions: Insulin Resistance
Obesity
Vitamin D25 Insufficiency

Interventions: Drug: Vitamin D drops
Drug: Placebo drops

First Posted Date: 2011-07-01

Last Posted Date: 2011-07-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 110

Registration Number: NCT01386736

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

Terminated

Conditions: Immune Thrombocytopenia

Interventions: Drug: Discontinuation of eltrombopag

First Posted Date: 2011-07-01

Last Posted Date: 2018-07-17

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 35

Registration Number: NCT01386723

Locations: 🇺🇸
Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, United States

Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Phase 1

Completed

Conditions: Esophageal Cancer
Malignant Neoplasm of Cardio-esophageal Junction of Stomach

Interventions: Drug: Azacitidine
Drug: Oxaliplatin
Drug: Epirubicin
Drug: Capecitabine

First Posted Date: 2011-07-01

Last Posted Date: 2018-12-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 12

Registration Number: NCT01386346

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy